AAX Biotech to present technologies at Festival of Biologics

AAX Biotech is set to participate in the Festival of Biologics 2025, held in Basel, Switzerland, from September 30 to October 2, 2025. Dr. Kushal Sejwal, Business Developer at AAX Biotech, will present a poster detailing the company's technological offerings.

The presentation will highlight AAX Biotech's Seqitope® platform for high-resolution, high-throughput epitope mapping and its Opti-mAb® platform designed for stabilizing scFv antibody fragments. These technologies are aimed at accelerating the development of antibody-based therapeutics.

Festival of Biologics is a key European event for professionals involved in the biologics pipeline, covering antibody engineering, cell and gene therapies, and immunotherapies. The event spans the entire development cycle, from discovery to commercialization.

AAX Biotech aims to connect with attendees to discuss potential collaborations and industry trends, emphasizing how its platforms can advance antibody therapeutic development.